Drugs / CKD-389
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04322032 | Apr → May 2020 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-389 | “CKD-389 Tab. 1 Tab.(Total 1 Tab.), Single oral administration under fasting condition.” NCT04322032 ↗ |
| Route | Oral | “Single oral administration under fasting condition.” NCT04322032 ↗ |